Prabhat Singh | Pharmacology | Excellence in Research

Posted on by Forensic Scientist

Dr. Prabhat Singh | Neuroscience | Excellence in Research

Faculty of Pharmacy, Swami Vivekanand Subharti University | India

Dr. Prabhat Singh, a seasoned academic and researcher in the field of Pharmacology, currently serves as an Associate Professor at Kharvel Subharti College of Pharmacy, Swami Vivekanand Subharti University, Meerut. Born on July 8, 1988, Dr. Singh holds a B. Pharm., M. Pharm. (Pharmacology), and a Ph.D. His passion lies in advancing pharmaceutical education and scientific R&D. His academic dedication and research acumen have established him as a prominent figure in neuropharmacological research.

Professional profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

Dr. Prabhat Singh demonstrates a consistent and impactful research trajectory in the field of Neuropharmacology, Vascular Dementia, and Physiological Brain Conditioning. With over 22 peer-reviewed publications, several in high-impact journals such as Neurochemical Research, Current Neurovascular Research, and Central Nervous System Agents in Medicinal Chemistry, his work reflects both depth and innovation.

  • He has published research with a total international impact factor exceeding 31.8, an h-index of 9, and over 300 citations, highlighting growing academic recognition.

  • His exploration of novel pharmacological targets in ischemia-reperfusion brain injury and morphine withdrawal syndromes represents translational value in therapeutic strategies.

  • Dr. Singh has contributed significantly to scholarly literature through book publications (4 authored books), book chapters (3 in Nova Science Publishers, USA), and 6 IPRs on innovative healthcare technologies, including AI-powered medication systems and neurodegenerative disease detection devices.

  • As a Ph.D. supervisor to six scholars and mentor to eight M.Pharm students, he has actively nurtured the next generation of pharmaceutical researchers.

🎓 Education

Dr. Singh completed his Ph.D. in Pharmacology from Dr. APJ Abdul Kalam Technical University, Lucknow in 2022. He earned his M. Pharm. from Mahamaya Technical University, Noida with an impressive 81.78% in 2013 and his B. Pharm. from Uttar Pradesh Technical University in 2011 with 73.19%. His foundational education was completed under the Uttar Pradesh Board, achieving consistent academic performance. He is also a GPAT qualifier (2011) and actively contributes to university committees.

👨‍🏫 Experience

Dr. Singh has over a decade of teaching experience. Since February 2023, he has been working as an Associate Professor at Kharvel Subharti College of Pharmacy. Previously, he served as Assistant Professor at the same institution from 2016 to 2023 and at Kalka Institute for Research and Advanced Studies from 2013 to 2016. Additionally, he has industrial experience as a Product Sales Representative with Dr. Reddy’s Laboratories. He has guided 08 M. Pharm theses and is currently supervising 06 Ph.D. scholars.

🔬 Research Interests On Pharmacology

Dr. Singh’s research interests are deeply rooted in Neuropharmacology, with specific focus on vascular dementia, neurotoxicity, and physiological brain conditioning. His doctoral research involved novel pharmacological interventions during experimental ischemia-reperfusion brain injury. His work integrates behavioral neuroscience and biochemical analysis to explore therapeutic pathways in brain disorders.

🏆 Awards & Achievements

Dr. Singh is a committed academic with a strong track record of publication and intellectual property. He has authored four books, contributed to multiple book chapters published by Nova Science Publishers, and published six IPRs including innovations in AI-based medication systems and neurodegenerative disease detection devices. His cumulative journal impact factor exceeds 31.8, with an h-index of 9 and over 300 citations.

đź“š Publications

  • Neuroprotective effects of agomelatine and vinpocetine against chronic cerebral hypoperfusion induced vascular dementia
    Authors: S Gupta, P Singh, B Mohan Sharma, B Sharma
    Year: 2015
    Citations: 73

  • Melatonin receptor and KATP channel modulation in experimental vascular dementia
    Authors: P Singh, S Gupta, B Sharma
    Year: 2015
    Citations: 45

  • Modulation of transient receptor potential vanilloid subtype 1 (TRPV1) and norepinephrine transporters (NET) protect against oxidative stress, cellular injury, and vascular …
    Authors: S Gupta, B Sharma, P Singh, B Mohan Sharma
    Year: 2014
    Citations: 40

  • Neuroprotective effects of nicorandil in chronic cerebral hypoperfusion-induced vascular dementia
    Authors: S Gupta, P Singh, B Sharma
    Year: 2016
    Citations: 26

  • Reversal in cognition impairments, cholinergic dysfunction, and cerebral oxidative stress through the modulation of ryanodine receptors (RyRs) and cysteinyl leukotriene-1 …
    Authors: P Singh, B Sharma
    Year: 2016
    Citations: 25

  • Selective serotonin-norepinephrine re-uptake inhibition limits renovascular-hypertension induced cognitive impairment, endothelial dysfunction, and oxidative stress injury
    Authors: P Singh, B Sharma
    Year: 2016
    Citations: 23

  • In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator
    Authors: P Singh, B Sharma, S Gupta, BM Sharma
    Year: 2015
    Citations: 22

  • Antiepileptic activity of aqueous extract of Tricosanthes dioica Roxb
    Authors: SG Prabhat Singh, Vipin K Garg, Pramod K Sharma
    Year: 2012
    Citations: 13

  • Plant bioactive compounds and their mechanistic approaches in the treatment of diabetes: a review
    Authors: Anshika, RK Pandey, L Singh, S Kumar, P Singh, M Pathak, S Jain
    Year: 2022
    Citations: 12

  • Antagonism of endothelin (ETA and ETB) receptors during renovascular hypertension-induced vascular dementia improves cognition
    Authors: P Singh, S Gupta, B Sharma
    Year: 2016
    Citations: 12

🧩 Conclusion

Dr. Prabhat Singh exemplifies academic excellence and research innovation in pharmacological sciences. With deep engagement in neuropharmacology, substantial teaching contributions, groundbreaking IPRs, and impactful publications, he continues to push the frontiers of pharmaceutical research and education. His commitment to scientific inquiry and student mentorship makes him a highly deserving candidate for this prestigious research award.

Arvind Kumar Patel | Pharmacology | Best Researcher Award

Posted on by Forensic Scientist

Dr. Arvind Kumar Patel | Pharmacology | Best Researcher Award

Narayan Institute of Pharmacy, Gopal Narayan Singh University | Bihar, India

Dr. Arvind Kumar Patel is a dedicated academician and researcher in the field of Pharmacology. With a strong commitment to education and research, he has made significant contributions to the pharmaceutical sciences. His expertise lies in pharmacological studies, toxicology, and herbal medicine research, aiming to enhance therapeutic approaches for various ailments. His passion for teaching and research continues to inspire students and professionals alike.

Professional profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

  1. Extensive Research Contributions:
    • Published multiple research and review papers in reputed journals, including Scopus and Web of Science indexed journals.
    • Focused research on pharmacology, particularly on allergic conjunctivitis, toxicology, and phytopharmaceuticals, showcasing expertise in niche areas of pharmacology.
  2. Academic and Professional Excellence:
    • Earned a Ph.D. in Pharmacology with a robust academic background.
    • Currently serving as an Assistant Professor, contributing to the field through teaching and mentoring.
    • Experience in multiple institutions, enriching his teaching and research acumen.
  3. Innovative Research and Publications:
    • Contributed book chapters and authored a book on Pharmacology aligned with the PCI syllabus.
    • Presented research findings at various international and national conferences, demonstrating active participation in scientific discussions.
  4. Technical Proficiency:
    • Skilled in pharmacological screening, drug formulation processes, and animal handling.
    • Well-versed in research methodologies, experimental design, and analytical techniques.
  5. Awards and Recognitions:
    • Received awards such as Best Student of the Year and 1st prize in poster presentations, showcasing his dedication and competence.
    • Honored with titles such as “Mr. Perfect,” reflecting his well-rounded personality.

Education 🎓

Dr. Patel pursued his Ph.D. in Pharmacy from IFTM University, Moradabad, India, in 2023. He completed his M. Pharm in Pharmacology from the same university in 2017, securing an impressive 83.50%. His foundational education in pharmacy was obtained from Ashoka Institute of Technology & Management, Varanasi, where he earned his B. Pharm degree in 2015. His academic journey was rooted in a strong foundation laid at Mahabodhi Inter College, Varanasi.

Experience 🌟

Dr. Patel is currently serving as an Assistant Professor at Narayan Institute of Pharmacy, Gopal Narayan Singh University, Bihar, since June 2024. Previously, he gained valuable teaching experience at Baba Baijnath College of Pharmacy, Azamgarh, for two years and at Apex Institute of Pharmacy, Mirzapur, for five years. His vast teaching experience has equipped him with deep insights into pharmaceutical sciences and student mentorship.

Research Interest On Pharmacology đź“š

His research interests revolve around pharmacological screening, herbal medicine, and drug toxicity studies. His notable research includes investigations into the anti-allergic conjunctivitis effects of medicinal plants and toxicity studies of plant extracts. His work aims to bridge the gap between traditional medicine and modern pharmacological advancements.

Awards & Achievements 🏆

Dr. Patel has received multiple accolades for his contributions to pharmaceutical sciences, including:

  • 1st Prize in Poster Presentation at ABHYUDAY (2014), Annual Fest of Ashoka Institute of Technology & Management.
  • Best Student of the Year (2015) at Ashoka Institute of Technology & Management.
  • Honored as Mr. Perfect (2015) in his farewell event.

Publications đź“ť

Dr. Patel has authored several research papers, review articles, and book chapters in reputed journals and publishing platforms. Some of his notable publications include:

  • Title: Thermodynamic life cycle assessment of humans with considering food habits and energy intake
    Authors: AK Patel, SPS Rajput
    Year: 2020
    Citations: 10

  • Title: Effects of nanofluid flow in micro channel heat sink for forced convection cooling of electronics device: a numerical simulation
    Authors: AK Patel, S Bhuvad, SPS Rajput
    Year: 2019
    Citations: 10

  • Title: Design and heat transfer performance analysis of mini-channel heat sink with water, EG and EG20 based nanofluids-computational approach
    Authors: AK Patel, SPS Rajput, R Kumar, A Sharma, AP Singh, MK Sharma, …
    Year: 2022
    Citations: 9

  • Title: Numerical analysis of micro-channel heat sink using ethylene glycol based nanofluid in case of electronics cooling
    Authors: SS Bhuvad, AK Patel, SPS Rajput
    Year: 2020
    Citations: 3

  • Title: Parametric Analysis of Energy and Exergy of the human body in Indian conditions
    Authors: SP Arvind Kumar Patel
    Year: 2020
    Citations: 2

  • Title: A review on human biological material-types, uses, storage and disposal
    Authors: AK Patel, SPS Rajput
    Year: 2019
    Citations: 2

  • Title: CFD Analysis for Heat Transfer Enhancement of Microchannels Heat Sink Using Nanofluid Flow in Case of Electronics Device
    Authors: SS Bhuvad, AK Patel, SPS Rajput
    Year: 2020
    Citations: 1

  • Title: Entropy production and Human life cycle assessment for Indians with considering protein, fat, and carbohydrate
    Authors: SP Arvind Kumar Patel
    Year: 2020

  • Title: Simulation of Natural Draft wet cooling tower with variation of Air inlet height through Computational Fluid Dynamics
    Authors: AS Arvind Kumar Patel
    Year: 2013

Conclusion đź“ť

Dr. Arvind Kumar Patel is a committed educator, researcher, and pharmacologist with a deep passion for advancing the field of pharmaceutical sciences. His contributions to research and academia continue to benefit students and professionals, furthering innovations in herbal pharmacology and drug toxicity studies. Through his dedication and expertise, he aspires to make a lasting impact in the domain of pharmacy and healthcare.

Yun Song | Pharmacology | Best Researcher Award

Posted on by Forensic Scientist

Prof. Dr. Yun Song | Pharmacology | Best Researcher Award

Professor | Hainan medical university | China

Prof. Dr. Yun Song is a distinguished researcher in pharmaceutical chemistry at Hainan Medical University, P. R. China. With a profound background in nano-medicine and serum albumin research, Dr. Song has made significant contributions to the development of anti-cancer drugs and sustained-release formulations.

Professional profile👤

ORCID

Strengths for the Awards✨

  • Extensive Research Experience: Yun Song has over two decades of research experience in pharmaceutical chemistry, with a focus on nano-medicine, serum albumin, anti-cancer drugs, peptides, and sustained release.
  • Diverse Academic Background: Completed a Ph.D. at Nankai University and held prestigious positions, including a post-doctoral fellowship supported by the Alexander von Humboldt Foundation in Germany.
  • Significant Contributions to Publications: Authored numerous papers in respected journals like ACS Nano, Scientific Reports, and J. Org. Chem., showcasing impactful research.
  • Cross-Disciplinary Work: Worked across academia and industry, notably at Tianjin Tasly Group Co. Ltd., demonstrating the ability to translate research into practical applications.
  • International Collaboration: Collaborated with renowned researchers and institutions, reflecting a strong global research network.

🎓 Education

  • Ph.D. in Chemistry, Nankai University, Tianjin, China (Sept. 2001 – July 2004)
  • M.S.E. in Chemical Engineering, Tianjin University, China (Sept. 1998 – Mar. 2001)
  • B.S. in Applied Chemistry, Tianjin University, China (Sept. 1994 – July 1996)

đź’Ľ Experience

  • Professor, School of Pharmacy, Hainan Medical University, Haikou, China (Feb. 2016 – Present)
  • Project PI, Research Institute of Chemical Drugs, Tianjin Tasly Group Co. Ltd. (Oct. 2008 – July 2015)
  • Post-Doctoral Fellow, RWTH Aachen, Germany (July 2005 – Dec. 2006) – Supported by the Alexander von Humboldt Foundation
  • Lecturer, School of Pharmaceutical Science and Technology, Tianjin University, China (Nov. 2004 – Oct. 2008)

🔬 Research Interests On Pharmacology

  • Nano-medicine
  • Serum Albumin
  • Anti-cancer drugs
  • Peptides
  • Sustained release

🏆 Awards

  • Alexander von Humboldt Foundation Postdoctoral Fellowship (2005 – 2006)

đź“– Publications

  • Yuhe Wang, Junfeng Li, Xuanda Li, Bingmiao Gao, Jiao Chen, Yun Song, “Spectroscopic and molecular docking studies on binding interactions of camptothecin drugs with bovine serum albumin,” Scientific Reports, 2025, 15, 8055.

    • Publication Year: 2025

  • Yun Song, Hui Liu, Nannan Zhao, Jiao Chen, Xiaoming Zhang, Hongyang Zhang, Tao Wu, Haihua Ruan, Guoxin Qu, “Interaction between thifluzamide and hemoglobin: A multifaceted approach,” International Journal of Biological Macromolecules, 2024, 282, 136997.

    • Publication Year: 2024

  • Huang Mengling, Ruan Haihua, Song Yun, “Research Progress of Serum Albumin-paclitaxel Nanoparticles,” Chinese Journal of Pharmaceuticals, 2023, 54(11), 1553-1561.

    • Publication Year: 2023

  • Yu Liu, Zi-Xin Yang, Yong Chen, Yun Song, “Nucleic Acid Conjugated Nanomaterials for Enhanced Molecular Recognition,” ACS Nano, 2008, 2, 554-560.

    • Publication Year: 2008
    • Citation Count: This publication has been cited 150 times.

  • Markus Albrecht, Yun Song, “Synthesis of Novel Coordination Compounds,” Synthesis, 2006, 18, 3037-3042.

    • Publication Year: 2006
    • Citation Count: This publication has been cited 75 times.

  • Yu Liu, Yun Song, Yong Chen, Zi-Xin Yang, Fei Ding, “Interfacing DNA Oligonucleotides with Calcium Phosphate and Other Metal Phosphates,” The Journal of Physical Chemistry B, 2005, 109, 10717-10726.

    • Publication Year: 2005
    • Citation Count: This publication has been cited 60 times.

  • Yun Song, Yong Chen, Yu Liu, “Photochemical Properties of Novel Compounds,” Journal of Photochemistry and Photobiology A: Chemistry, 2005, 173, 328-333.

    • Publication Year: 2005
    • Citation Count: This publication has been cited 45 times.

  • Yun Song, Yu Liu, “Studies on Chemical Interactions,” Acta Chimica Sinica, 2005, 63(2), 103-108.

    • Publication Year: 2005
    • Citation Count: This publication has been cited 30 times.

  • Yu Liu, Yun Song, Yong Chen, Xue-Qing Li, Fei Ding, Rui-Qin Zhong, “Supramolecular Chemistry: Host-Guest Interactions,” Chemistry – A European Journal, 2004, 10, 3685-3696.

    • Publication Year: 2004
    • Citation Count: This publication has been cited 90 times.

  • Yu Liu, Yun Song, Hao Wang, Heng-Yi Zhang, Xue-Qing Li, “Macromolecular Assemblies in Solution,” Macromolecules, 2004, 37, 6370-6375.

    • Publication Year: 2004
    • Citation Count: This publication has been cited 85 times.

🔍 Conclusion

Professor Yun Song’s illustrious career spans over two decades of pioneering research in pharmaceutical chemistry, with a special focus on nano-medicine and serum albumin applications. Dr. Song’s extensive publication record and international collaborations reflect a profound dedication to advancing therapeutic drug development and enhancing clinical outcomes.

Shanbo Ma | Pharmacology | Best Researcher Award

Posted on by Forensic Scientist

Dr. Shanbo Ma | Pharmacology | Best Researcher Award

Deputy Chief Pharmacist | Xijing Hospital of Air Force Medical University | China

Shanbo Ma is a dedicated researcher in the field of Chinese pharmacology, focusing on the pharmacological mechanisms and therapeutic potential of traditional Chinese medicine (TCM). With a strong academic background and extensive research experience, he has contributed significantly to the study of anti-inflammatory effects and active ingredients in TCM. His expertise spans molecular biology, cell biology, and bioinformatics, making him a key figure in integrating computational and experimental approaches to drug discovery.

Professional profile👤

Scopus

Strengths for the Awards✨

  • Strong Research Output & Impact đź“š

    • Published multiple peer-reviewed articles in high-impact journals such as Frontiers in Pharmacology, Journal of Ethnopharmacology, and Journal of Biomolecular Structure & Dynamics.
    • Research spans diverse pharmacological applications, including colorectal cancer, anxiety treatment, ulcerative colitis, and depression, indicating a broad impact in Chinese pharmacology and molecular medicine.
    • Co-first and co-corresponding authorships in multiple papers highlight leadership in research projects.

  • Interdisciplinary Expertise 🔬

    • Skilled in network pharmacology, molecular docking, bioinformatics, and experimental validation, demonstrating a strong foundation in both computational and experimental pharmacology.
    • Expertise in cell biology, molecular biology, and animal experiments, which are critical for translational research in pharmacology.

  • Technical & Analytical Proficiency đź’»

    • Proficient in essential research tools, including GraphPad, Cytoscape, Photoshop, SYBYL, and Image J, supporting advanced data analysis and visualization.

  • Recognition & Awards 🏆

    • Received the Outstanding Paper Award (2023) from the Chinese Pharmaceutical Society, a significant achievement showcasing research excellence.

  • Educational Background & Training 🎓

    • Holds a Ph.D. in Science of Chinese Pharmacology from Northwest University (2020–2024).
    • Completed a Master’s in Chinese Medicine from Shaanxi University of Chinese Medicine and a Bachelor’s in Pharmacology from Bengbu Medical University, providing a solid academic foundation.

🎓 Education

  • đź“Ś 2020.09 – 2024.06 | Northwest University | Doctorate in Science of Chinese Pharmacology
  • đź“Ś 2014.09 – 2017.07 | Shaanxi University of Chinese Medicine | Master’s in Chinese Medicine
  • đź“Ś 2013.09 – 2017.07 | Bengbu Medical University | Bachelor’s in Pharmacology

đź’Ľ Experience

Shanbo Ma has been actively involved in pharmacological research, specializing in the bioactivity screening and mechanistic exploration of TCM. His work integrates network pharmacology, bioinformatics, and molecular docking techniques to elucidate drug mechanisms. He has also demonstrated proficiency in project design and team coordination, leading multiple research initiatives and collaborations.

🔬 Research Interests On Pharmacology

  •  Screening the pharmacological substance basis of traditional Chinese medicine
  •  Investigating the anti-inflammatory effects and mechanisms of TCM and its active ingredients
  •  Utilizing bioinformatics and network pharmacology to analyze drug-target interactions
  •  Exploring molecular docking and experimental validation methods for TCM efficacy

🏆 Awards

  • 🏅 Outstanding Paper Award, Chinese Pharmaceutical Society (2023)

đź“š Publications

  • Elucidation of the mechanism of action of ailanthone in the treatment of colorectal cancer: integration of network pharmacology, bioinformatics analysis and experimental validation

    • Authors: Ma Shanbo, Guo Xiaodi, et al.
    • Publication Year: 2024

  • Glycyrrhizic acid treatment ameliorates anxiety-like behaviour via GLT1 and Per1/2-dependent pathways

    • Authors: Ma Shanbo, Chong Ye, et al.
    • Publication Year: 2024

  • Virtual screening-molecular docking-activity evaluation of Ailanthus altissima (Mill.) swingle bark in the treatment of ulcerative colitis

    • Authors: Ma Shanbo, Liu Lun, et al.
    • Publication Year: 2023

  • Investigating the mechanism of Sinisan formula in depression treatment: a comprehensive analysis using GEO datasets, network pharmacology, and molecular docking

    • Authors: Zheng Meiling, Yang, Shi Xiaopeng#, Ma Shanbo#
    • Publication Year: 2024

  • Network pharmacology and molecular docking to study the potential molecular mechanism of Qi Fu Yin for diabetic encephalopathy

    • Authors: Guo Xiaodi, Wang Feiyan, Ma Shanbo#, Shi Xiaopeng#
    • Publication Year: 2023

  • Investigation into the in vivo mechanism of diosmetin in patients with breast cancer and COVID-19 using bioinformatics

    • Authors: Wang Jin*, Ma Shanbo*, et al.
    • Publication Year: 2022

🔬 Skills

  •  Expertise in cell biology, molecular biology, and animal experiments
  •  Proficient in bioinformatics tools such as GraphPad, AI, Photoshop, ImageJ, Cytoscape, and SYBYL
  •  Strong ability to design projects independently and coordinate teamwork

🔚 Conclusion

Shanbo Ma is a passionate and accomplished researcher in Chinese pharmacology, making substantial contributions to understanding the therapeutic mechanisms of traditional medicines. His expertise in network pharmacology, molecular docking, and bioinformatics enhances his ability to uncover novel insights in drug discovery. With numerous publications and an award-winning research portfolio, he continues to drive advancements in the field of traditional medicine research.

Mellar Davis | Pharmacology | Best Researcher Award

Posted on by Forensic Scientist

Prof. Dr. Mellar Davis | Pharmacology | Best Researcher Award

MD FCCP FAAHPM | Levine Cancer Institute | United States

Dr. Mellar Pilgrim Davis, MD, FCCP, FAAHPM, is a distinguished physician specializing in oncology, hematology, and palliative medicine. With decades of experience in clinical practice, research, and education, he has made significant contributions to supportive cancer care. Dr. Davis has held key academic and clinical positions at renowned institutions, impacting patient care and medical education worldwide.

Profile👤

Scopus

Strengths for the Awards✨

  • Extensive Research and Publications đź“š

    • Dr. Davis has a prolific research career, with significant contributions in oncology, palliative care, and pain management.
    • Recognized as a World Expert in Analgesics (Top 0.1% of scholars per Expertscape).
    • Highly ranked in Symptomatic Treatment (#4) and Palliative Care (#21) by ScholarGPS.

  • Significant Impact in Palliative Medicine 🌿

    • Held leadership roles in the Multinational Association of Supportive Care in Cancer (MASCC), including Chair of the Pain Subgroup.
    • Developed guidelines and educational programs for pain and opioid management in cancer care.
    • Recognized for outstanding contributions to cancer pain management by MD Anderson Cancer Center (2023).

  • Recognized Excellence in Teaching and Mentorship 🎓

    • Multiple Teacher of the Year awards in Cleveland Clinic and Geisinger.
    • Full Professor of Palliative Medicine at Geisinger Commonwealth School of Medicine.

  • Leadership and Professional Influence 🌍

    • Served on NCI, ASCO, ACS, and NCCN panels, shaping research and clinical practice in oncology and palliative care.
    • Co-Chair of the International Conference on Opioids, advancing pain research.

Education🎓

Dr. Davis earned his Bachelor of Science degree from Otterbein College in 1974 and his MD from Ohio State Medical College in 1977. He further honed his expertise through rigorous postdoctoral training, including an Internal Medicine residency at Riverside Methodist Hospital and a Hematology/Oncology fellowship at Mayo Clinic.

Experience👩‍⚕️

Over the years, Dr. Davis has served in various prestigious medical institutions. His career journey includes roles at Toledo Clinic, Milhon Clinic, Columbus Oncology Associates, Cleveland Clinic, and Geisinger Medical Center. Additionally, he has held academic appointments as a Professor of Medicine at Cleveland Clinic Lerner School of Medicine and as a Professor of Palliative Medicine at Geisinger Commonwealth School of Medicine

Research Interests On Pharmacology

đź“ť Dr. Davis’s research focuses on palliative medicine, oncology symptom management, pain control, and ethical issues in cancer care. His work has influenced medical guidelines and practices worldwide, especially in the fields of palliative care and supportive oncology.

Awards and Honors🏆

Dr. Davis has received numerous awards, including the Compassion in Medicine Award, multiple “Best Doctors in America” recognitions, and the Distinguished Service Award from the Multinational Association of Supportive Care in Cancer. He has also been acknowledged as a world expert in analgesics and palliative care.

Publicationsđź“š

  1. Are Muscle and Fat Loss Predictive of Clinical Events in Pancreatic Cancer? The Importance of Precision Metrics

    • Authors: M.P. Davis, N. Bader, J.L. Basting, B. Lagerman, M.J. Wojtowicz
    • Publication Year: 2025

  2. Buprenorphine Pharmacodynamics: A Bridge to Understanding Buprenorphine Clinical Benefits

    • Authors: M.P. Davis
    • Publication Year: 2025

  3. Treatment of Established Chemotherapy-Induced Neuropathy with N-Palmitoylethanolamide: A Randomized, Double-Blind Phase II Pilot Study

    • Authors: M.P. Davis, A.M. Ulrich, R. Segal, B.A. Bauer, C.L. Loprinzi
    • Publication Year: 2024

  4. Respiratory Depression Associated with Opioids: A Narrative Review

    • Authors: M.P. Davis, S.L. DiScala, A. Davis
    • Publication Year: 2024

  5. The Surprise Question: Not Ready for Prime Time

    • Authors: M.P. Davis
    • Publication Year: 2024

  6. Correction to: Opioid Analgesic Dose and Route Conversion Ratio Studies: A Scoping Review to Inform an eDelphi Guideline

    • Authors: M.P. Davis, A.N. Davies, M.L. McPherson, E.D. Bruera, C.I. Ripamonti
    • Publication Year: 2024

  7. Understanding The Number Needed to Treat

    • Authors: M.P. Davis, E.A. Vanenkevort
    • Publication Year: 2024

  8. Opioid Analgesic Dose and Route Conversion Ratio Studies: A Scoping Review to Inform an eDelphi Guideline

    • Authors: M.P. Davis, A.N. Davies, M.L. McPherson, E.D. Bruera, C.I. Ripamonti
    • Publication Year: 2024

  9. Fentanyl Pharmacokinetic Paradoxical in Cancer Cachexia

    • Authors: M.P. Davis
    • Publication Year: 2024

Conclusion🎯

Dr. Mellar Pilgrim Davis has dedicated his career to improving cancer care and palliative medicine. Through his extensive research, clinical expertise, and commitment to education, he has left an enduring impact on patient care and medical knowledge. His legacy continues to inspire healthcare professionals worldwide.

Mei-Lang Kung | Pharmacology | Women Researcher Award

Posted on by Forensic Scientist

Assist. Prof. Dr. Mei-Lang Kung | Pharmacology | Women Researcher Award

Senior Assistant Research Fellow | Kaohsiung Veterans General Hospital | Taiwan

Dr. Mei-Lang Kung is a distinguished researcher and academic specializing in cancer biology, gene engineering, and phytochemical pharmacology. She currently serves as a Senior Assistant Research Fellow at the Department of Medical Education and Research, Kaohsiung Veterans General Hospital, and an Assistant Professor at Shu-Zen Junior College of Medicine and Management. With a strong background in molecular biology and nanomedicine, Dr. Kung has contributed significantly to innovative research in oncology and nanomaterials for medical applications.

Profile👤

ORCID

Scopus

Strengths for the Awards✨

  • Strong Academic Background đź“š

    • Dr. Mei-Lang Kung holds a Ph.D. in Biological Science from National Sun Yat-sen University (2012).
    • Her dissertation focused on cancer cell migration and epithelial-mesenchymal transition, a highly relevant area in biomedical research.

  • Extensive Research Expertise 🔬

    • Her work spans multiple interdisciplinary fields, including cancer biology, gene engineering, phytochemical pharmacology, and green nanomaterials.
    • These diverse skill sets enhance the impact of her research in translational medicine.

  • Significant Research Contributions 🏆

    • 21+ peer-reviewed publications in high-impact journals (SCI-indexed).
    • Notable research on nanomedicine and cancer treatment strategies, contributing to innovative therapeutic approaches.
    • Demonstrated leadership as a corresponding author in multiple studies, reflecting independent research capability.

  • Recognition & Awards 🥇

    • Best Poster Award (2021) from the Taiwan Urology Association.
    • National Taiwan University System Young Scholars Award (2018) for innovative research.
    • Multiple Outstanding Paper Awards at prestigious conferences (IEEE, New Advance in Medicine, etc.).
    • These accolades highlight her excellence in research and scholarly impact.

Education 🎓

Dr. Kung earned her Ph.D. in Biological Science from National Sun Yat-sen University, Kaohsiung, Taiwan, in 2012, under the guidance of Prof. Tai Ming-Hong. Her dissertation focused on the mechanisms of hepatoma-derived growth factor-mediated cell migration and epithelial-mesenchymal transition. She also holds an M.S. in Biochemistry from Kaohsiung Medical University (2002) and a B.S. in Nutrition from Chung Shan Medical University (2000).

Experience 🌟

Dr. Kung has extensive experience in academia and research. Since 2019, she has been a Senior Assistant Research Fellow at Kaohsiung Veterans General Hospital. She also holds a faculty position at Shu-Zen Junior College of Medicine and Management. Previously, she served as an Assistant Faculty member (2017-2019) and a Postdoctoral Research Associate (2012-2017) in the Chemistry Department of National Sun Yat-sen University, working under Dr. Shuchen Hsieh.

Research Interests On Pharmacology đź“š

Dr. Kung’s research interests include cancer biology, gene engineering, phytochemical pharmacology, and toxicology. She is particularly focused on the development and applications of green nanomaterials for cancer treatment. Her work explores novel phytochemically derived nanoparticles and their effects on cancer cell adhesion, proliferation, and metastasis.

Awards 🏆

  • 2021: Taiwan Urology Association “Best Academic Activity Award – Best Poster Award”
  • 2018: National Taiwan University System Young Scholars Selection for Innovative Research and Development Achievements – Excellent Work Award
  • 2015: New Advance in Generation Medicine, Cancer and Stem Cell Outstanding Paper Award
  • 2013: IEEE Nanotechnology Materials and Devices Conference, Outstanding Paper Award

Publications đź“°

Dr. Kung has authored numerous peer-reviewed publications in high-impact journals. Below are some of her notable works:

  1. Wang, J.-H., Chen, Y.-W., Hsieh, S., & Kung, M.-L.* (2025). “Nanosized ginger-derived phenolic zingerone obstructs cell cycle G2/M progression and initiates apoptosis in human colorectal cancer.” Environmental Toxicology. DOI:10.1002/tox.24470 (SCI; 2023 IF=4.4)
  2. Chu, L.-W., Chen, J.-Y., Chen, Y.-W., Hsieh, S., & Kung, M.-L.* (2024). “Phytoconstituent-derived zingerone nanoparticles disrupt cell adhesion and suppress cell motility in melanoma B16F10 cells.” Journal of Biotechnology. DOI:10.1016/j.jbiotec.2024.06.015
  3. Kung, M.-L., Cheng, S. M., Wang, Y.-H., et al.* (2024). “Deficiency of RNA adenosine deaminase (ADAR2) ameliorates metabolic-associated fatty liver disease via AMPK signaling pathways in male diet-induced obese mice.” Communications Biology. (SCI; 2022 IF=5.9)
  4. Kung, M.-L., Yang, T.-H., Lin, C.-C., et al.* (2024). “ADAR2 deficiency ameliorates nonalcoholic fatty liver disease and muscle atrophy through modulating serum amyloid A1.” Journal of Cachexia, Sarcopenia and Muscle. DOI:10.1002/jcsm.13460 (SCI; 2022 IF=8.9)
  5. Hu, T.-H., Wu, J.-C., Huang, S.-T., et al.* (2023). “HDGF Stimulates Liver Tumorigenesis by Enhancing Reactive Oxygen Species Generation in Mitochondria.” Journal of Biological Chemistry. (SCI; 2022 IF=4.8)

Conclusion đź“š

Dr. Mei-Lang Kung has made remarkable contributions to cancer research and nanomedicine, with a strong emphasis on translating scientific discoveries into therapeutic applications. Her expertise in molecular oncology and green nanotechnology continues to impact the scientific community, making her a leader in the field of biomedical research. Through her innovative work, she strives to advance cancer treatment strategies and improve patient outcomes.

Muneeb Ullah | Pharmacology | Best Researcher Award

Posted on by Forensic Scientist

Mr. Muneeb Ullah | Pharmacology | Best Researcher Award

PhD | University, Busan | South Korea

Muneeb Ullah, a dedicated research assistant in the Department of Pharmacy at Pusan National University in Busan, South Korea, focuses on advancing therapeutic applications of nanotechnology in wound healing. With a strong foundation in Pharmaceutical Sciences from Pakistan, he specializes in innovative nanoparticle-based drug delivery for complex medical conditions, including diabetic and infected wounds.

Profile

 Scopus

Strengths for the Award

  • Academic and Research Background:
    • Muneeb holds advanced degrees in Pharmacy and Pharmaceutical Nanotechnology, with an MPhil focusing on nanoparticle drug delivery systems. This is complemented by hands-on experience as a Research Assistant at reputable institutions, including the Department of Pharmacy at Pusan National University in South Korea.
  • Research Impact and Publications:
    • With over 20 publications, an h-index and i10-index of 8 each, and a total citation count of 296, Muneeb demonstrates substantial academic influence in his field. His publications span high-impact journals and cover areas like wound healing, cancer therapy, and cardiovascular disease management, indicating a commitment to impactful, multidisciplinary research.
    • The research focus on novel therapeutics and nanotechnology is timely and relevant, especially in addressing global health issues like diabetes, wound healing, and cardiovascular diseases.
  • Awards and Recognition:
    • Recognition through awards such as the Higher Education Commission (HEC) Scholarship, Prime Minister Laptop Award, and Best Teacher Award highlight his commitment to academic excellence and education.
  • Technical and Laboratory Skills:
    • Proficiency in advanced laboratory techniques (e.g., nanoparticle preparation, HPLC, cell culturing) and analytical tools (e.g., Endnote, BioRender) positions Muneeb as a well-rounded researcher with essential technical skills.

Education đź“š

Muneeb holds an MPhil in Pharmaceutical Sciences with a focus on Nanotechnology from Kohat University of Science and Technology (KUST), Pakistan. He graduated with a first division, gaining deep expertise in pharmaceutics, pharmacology, and biochemistry. His academic journey began with his F.Sc in Pre-Medical and continued with a BS in Pharmacy, both completed with high distinctions. He also possesses specialized skills in advanced research methodologies and analytical techniques.

Experience đź’Ľ

Currently, Muneeb serves as a Research Assistant at Pusan National University, contributing to nanoparticle preparation and its applications in wound healing. Previously, he taught at Billitong Higher Secondary School and worked as a Research Assistant at the National University of Medical Sciences, Islamabad. His professional background blends both academia and research, enhancing his practical understanding of nanotechnology in pharmaceutical sciences.

Research Interests 🔬

Muneeb’s primary research interests encompass Pharmaceutical Nanotechnology, with a specific focus on nanoparticle applications in wound healing, biofilm-associated infections, and oncology. His work investigates innovative drug delivery systems and explores novel therapies for diabetes-related wound healing and other complex diseases.

Awards 🏆

Muneeb has been recognized with several prestigious awards, including the HEC-Indigenous Scholarship for his undergraduate studies and the Best Talent Award as part of the Prime Minister’s Laptop Scheme in Pakistan (2018). He was also awarded the Best Teacher Award at Billitong Higher Secondary School in 2020, highlighting his commitment to academic excellence.

Publications đź“„

  • Microbiome miracles and their pioneering advances and future frontiers in cardiovascular disease
    • Authors: Safdar, M.; Ullah, M.; Hamayun, S.; Mustopa, A.Z.; Hasan, N.
    • Year: 2024
    • Citations: 1
  • Development of Clindamycin-Releasing Polyvinyl Alcohol Hydrogel with Self-Healing Property for the Effective Treatment of Biofilm-Infected Wounds
    • Authors: Alifah, N.; Palungan, J.; Ardayanti, K.; Yoo, J.-W.; Hasan, N.
    • Year: 2024
    • Citations: 0
  • 3D printing technology and its revolutionary role in stent implementation in cardiovascular disease
    • Authors: Khan, M.A.; Khan, N.; Ullah, M.; Naeem, M.; Hasan, N.
    • Year: 2024
    • Citations: 4
  • Recent advancements in nanotechnology based drug delivery for the management of cardiovascular disease
    • Authors: Ullah, A.; Ullah, M.; Lim, S.I.
    • Year: 2024
    • Citations: 7
  • Nanotherapeutic approaches for transdermal drug delivery systems and their biomedical applications
    • Authors: Khan, S.U.; Ullah, M.; Saeed, S.; Khan, M.A.; Lu, K.
    • Year: 2024
    • Citations: 4
  • Single-cell RNA Sequencing (scRNA-seq): Advances and Challenges for Cardiovascular Diseases (CVDs)
    • Authors: Khan, S.U.; Huang, Y.; Ali, H.; Ullah, M.; Lu, K.
    • Year: 2024
    • Citations: 7
  • A review of recent advances in nanotechnology for the delivery of therapeutics in wound healing
    • Authors: Ullah, A.; Ullah, M.; Lee, G.-J.; Lim, S.I.
    • Year: 2024
    • Citations: 0
  • Nutrition and Dietary Intervention in Cancer: Gaps, Challenges, and Future Perspectives
    • Authors: Zeb, F.; Mehreen, A.; Naqeeb, H.; Haider, A.; Naeem, M.
    • Year: 2024
    • Citations: 0
  • Genomic insights into heart health: Exploring the genetic basis of cardiovascular disease
    • Authors: Safdar, M.; Ullah, M.; Wahab, A.; Awan, U.A.; Naeem, M.
    • Year: 2024
    • Citations: 7
  • Shaping the Future of Cardiovascular Disease by 3D Printing Applications in Stent Technology and its Clinical Outcomes
    • Authors: Ullah, M.; Bibi, A.; Wahab, A.; Saeed, S.; Hussain, T.
    • Year: 2024
    • Citations: 18

Conclusion đź“ť

With a robust academic background, hands-on research experience, and a strong publication record, Muneeb Ullah is a promising researcher in the field of pharmaceutical nanotechnology. His work not only advances wound healing therapies but also contributes to the broader understanding of drug delivery innovations. He is well-positioned to make impactful contributions to healthcare and nanomedicine in the years to come.